PsyMed Ventures
psymed.venturesVCMatch tracks PsyMed Ventures as an investor focused on AI/ML, Healthtech, and Biotech companies and North America markets. Upload your deck to compare your startup against the full private matching profile.
Check Size
Not specified
Stages
Not specified
Focus Areas
Geography
North America
Investment Thesis
PsyMed Ventures funds founders who are elevating brain and mental health through innovative neuroscience and frontier technologies. The firm believes that founders should align three principles: healing, responsibility, and profitability. Their core conviction is that frontier technologies can transform the mental and brain illness epidemic into a flourishing future, operating across a broad spectrum of therapeutic approaches from novel compounds to digital health solutions.
Is PsyMed Ventures right for your startup?
Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.
Investment Focus
Who should take a closer look
PsyMed Ventures is most relevant for founders raising venture-backed rounds in AI/ML, Healthtech, Biotech, and Digital Health, especially across North America.
Focus statement
We invest in frontier technologies transforming the mental and brain illness epidemic into a flourishing future. The firm focuses on neurotech & BCI, digital health, precision neuroscience, platforms & novel therapeutics, and alternative modalities.
Value Add
- Broad investment thesis spanning multiple modalities: AI/ML, neurotech, precision neuroscience, genetic/RNA/cell therapies, holistic medicine, neurometabolism, psychedelic medicine, and digital therapeutics
- Strong portfolio with public exits (Alto Neuroscience, ATAI Life Sciences, Bright Minds) demonstrating ability to scale companies to IPO
- Deep scientific expertise with venture partners including former Neuralink founding member Tim Gardner and Yale psychiatry leader John Krystal
- Integrated ecosystem approach via podcast 'Business Trip' and newsletter, building community around mental health innovation
- Unique focus on neurometabolism and holistic medicine alongside traditional biotech, recognizing bidirectional relationship between metabolic processes and mental health
Stage And Sector Fit
Sectors
Portfolio Highlights
ALTO NEUROSCIENCE
Neuroscience|Precision Psychiatry
ANCILIA
Biotech|Crispr|Gene Therapy
ATAI LIFE SCIENCES
Neuroscience|Mental Health|Psychedelics
BECKLEY PSYTECH
Neuroscience|Psychedelics
BEXSON BIOMEDICAL
Biotech|Neuroscience
BLOOM SCIENCE
Biotech|Microbiome|Neuroscience
BRIGHT MINDS
Neuroscience|Psychedelics
DELIX THERAPEUTICS
Neuroscience|Psychedelics
+ 24 more companies in their portfolio
Investment Team
14 Partners at PsyMed Ventures
See who leads investments in your sector and how to connect with them.
Get partner details
Upload your deck to see who's the best fit for your startup.
Ready to find your perfect investor match?
Get Started Free